A breakthrough in fighting solid tumors with a novel trispecific targeting Nectin-4, CD3 and CD40 to overcome the immunosuppressive tumor microenvironment

APVO451 - Aptevo Therap

https://jitc.bmj.com/content/13/Suppl_2/A1358

Hieu N Nguyen 1; Jake S Foronda 2; Robert Miller 3; Megan Vik 4; Matthew J Bailey 5; Elizabeth B Lorentz 6; Diego Ic-Mex 7; Maria Dasovich 8; Michael McCrosson 9; Nicholas McClure 10; Tyler Rozanitis 11; Peter Pavlik 12; Michelle H Nelson 13

Oct 3, 2025